OptimizeRx Corp — Director's Dealing 2024

Aug 5, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: OptimizeRx Corp (OPRX)
CIK: 0001448431
Period of Report: 2024-08-02

Reporting Person: McCarthy Brian Clark (Chief Revenue Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-02	Stock Option	$10.49	A	18677	Acquired	2027-08-02	Common Stock (18677)	Direct
2024-08-02	Restricted Stock Units	$	A	9533	Acquired	2027-08-02	Common Stock (9533)	Direct

Footnotes

F1: The Stock Option will vest 1/3 at the end of each anniversary from issuance.

F2: Each restricted stock unit represents a contingent right to receive one share of OptimizeRx's common stock. The restricted stock units will vest 1/3 at the end of each anniversary from issuance. Any restricted stock unit that has not been earned and vested as of the third anniversary of the grant date will be forfeited. Vesting of the restricted stock units shall accelerate upon a qualifying termination.